| Sep 13 2024 |
Federal Circuit Says No Timing Requirement to Qualify as A POSITA |
Foley & Lardner LLP |
| Sep 13 2024 |
McDermott+ Check-Up: September 13, 2024 |
McDermott Will & Emery |
| Sep 13 2024 |
USDA and CDFA Declare California Free of Invasive Fruit Flies |
Keller and Heckman LLP |
| Sep 13 2024 |
10 Key Facts About Suboxone Lawsuits: What Patients and Families Need to Know |
Oberheiden P.C. |
| Sep 12 2024 |
IARC Releases Its Priority Evaluation List for 2025-2029 |
Nelson Mullins |
| Sep 12 2024 |
U.S. Chamber of Commerce Releases Report Examining Impact of Essential Fluorochemistries |
Bergeson & Campbell, P.C. |
| Sep 12 2024 |
NIOSH Blog Item Highlights NTRC’s Toxicology and Internal Dose Team |
Bergeson & Campbell, P.C. |
| Sep 12 2024 |
Blank Rome State of the Cannabis Industry Panelist Interview Series: Patrick Kim, Altmore Capital Co-Founder and Managing Director |
Blank Rome LLP |
| Sep 12 2024 |
Back to the Future: Expert Can Be Skilled Artisan Based on Later-Acquired Knowledge |
McDermott Will & Emery |
| Sep 11 2024 |
Registration Opens for NNI Webinar on Nanometrology for Continuous and Automated Manufacturing |
Bergeson & Campbell, P.C. |
| Sep 11 2024 |
California Legislature Passes Bill Requiring Fortification of Corn Masa with Folic Acid |
Keller and Heckman LLP |
| Sep 11 2024 |
Federal Appeals Court: Pay That Man His Money, Unless That Money Is Illegal Marijuana Money |
Bradley Arant Boult Cummings LLP |
| Sep 11 2024 |
300 Days Since Biden’s AI Executive Order: What Have Federal Agencies Accomplished and What is on the Horizon? |
Squire Patton Boggs (US) LLP |
| Sep 11 2024 |
Petitions Filed to Add Several Chemicals to List of Taxable Substances; Comments Due November 4, 2024 |
Bergeson & Campbell, P.C. |
| Sep 11 2024 |
This Week in 340B: September 3 – 9, 2024 |
McDermott Will & Emery |
| Sep 10 2024 |
NIFA Announces $5.3 Million Investment in Biotechnology Risk Assessment Research |
Bergeson & Campbell, P.C. |
| Sep 10 2024 |
FDA Rejects MDMA Treatment for PTSD; Setbacks and New Directions |
Womble Bond Dickinson (US) LLP |
| Sep 10 2024 |
FSIS Updates Guidance for Animal-Raising and Environmental Claims |
Keller and Heckman LLP |
| Sep 10 2024 |
BIOSECURE Act: Anticipated Movement, Key Provisions, and Likely Impact |
Foley & Lardner LLP |
| Sep 9 2024 |
Challenges in AI-Enabled Biomarker Discovery |
Foley & Lardner LLP |
| Sep 9 2024 |
Alabama Court Signals Possible Willingness to Allow Medical Program to Move Forward in Part |
Bradley Arant Boult Cummings LLP |
| Sep 9 2024 |
China Expands Pilot Program for Foreign Investment in the Healthcare Sector |
Sheppard, Mullin, Richter & Hampton LLP |
| Sep 6 2024 |
Dos and Don’ts for Advertising, Packaging and Labeling of Cannabis Products in Illinois |
Sheppard, Mullin, Richter & Hampton LLP |
| Sep 6 2024 |
DEA Will Hold Public Hearing to Address Marijuana Rescheduling |
Jackson Lewis P.C. |
| Sep 6 2024 |
Seasonal Considerations for Packaging and Selling Alcoholic Beverages |
McDermott Will & Emery |
| Sep 6 2024 |
DOD Announces Seven Awards via the Distributed Bioindustrial Manufacturing Program |
Bergeson & Campbell, P.C. |
| Sep 6 2024 |
McDermott+ Check-Up: September 6, 2024 |
McDermott Will & Emery |
| Sep 6 2024 |
Obtaining Clearances Through FDA's Food Contact Notification Program |
K&L Gates |
| Sep 6 2024 |
Federal Court Permits Investors to Resume Kickback Suit Against Teva |
ArentFox Schiff LLP |
| Sep 6 2024 |
FDA Publishes FY2022 Pesticide Residue Monitoring Program Report |
Keller and Heckman LLP |
| Sep 6 2024 |
HHS-OIG Declines Sanctions on Diabetes Patient Program Subsidizing Medicare Cost-Sharing |
Barnes & Thornburg LLP |
| Sep 6 2024 |
House Subcommittee Will Hold Legislative Hearing on Evaluating FDA Human Foods and Tobacco Programs |
Bergeson & Campbell, P.C. |
| Sep 6 2024 |
Plaintiff’s Attorney Spencer Sheehan Sanctioned |
Keller and Heckman LLP |
| Sep 6 2024 |
Looking For a Drink At 3 A.M.? Soon, You May Find One Here |
Allen Matkins Leck Gamble Mallory & Natsis LLP |
| Sep 5 2024 |
Class Action Litigation Newsletter | 2nd Quarter 2024 |
Greenberg Traurig, LLP |
